Dark Forest Capital Management »

Aeglea Biotherapeutics shares owned by Dark Forest Capital Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Dark Forest Capital Management from 13F filings

Historical chart of Dark Forest Capital Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Dark Forest Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Dark Forest Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $247k 15k 16.76

More positions owned by Dark Forest Capital Management

Loews Corp Common Stock (L)
Ishares Msci Brazil Etf Reit (EWZ)
Simon Property Group Common Stock (SPG)
Vanguard Ftse Emerging Marke Reit (VWO)
Ishares Msci India Etf Reit (INDA)
Capital One Financial Corp Common Stock (COF)
Booz Allen Hamilton Holdings Reit (BAH)
Goldman Sachs Group Common Stock (GS)
Walmart Common Stock (WMT)
Microsoft Corp Common Stock (MSFT)
Axis Capital Holdings Common Stock (AXS)
Cintas Corp Common Stock (CTAS)
Amazon.com Common Stock (AMZN)
Popular Common Stock (BPOP)
Ss Spdr S&p Biotech Etf Common Stock (XBI)

View all positions for Dark Forest Capital Management

Top funds holding Aeglea Biotherapeutics

FMR
Fairmount Funds Management
BlackRock
Rtw Investments
Tang Capital Management
Vanguard Group
VR Adviser
Braidwell
Capital Research and Management Company - Division 3
Driehaus Capital Management
Commodore Capital
State Street Corporation
Wellington Management Company
Paradigm Biocapital Advisors
Affinity Asset Advisors

View all funds holding Aeglea Biotherapeutics